Children whose mothers took antiepileptic drugs (AEDs) while pregnant are at increased risk of early development issues, according to a new study published in Epilepsia, a journal published by… read more.
The new study, which was led by Professor Carol Brayne, of the Cambridge Institute of Public Health (CIPH), University of Cambridge, UK, is part of the Medical Research… read more.
Poster 67 Elizabeth Goode elizabeth.goode@nnuh.nhs.uk. Chemotherapy is an independent risk factor for thromboembolism (TE), although current guidelines do not recommend routine use of anti-thrombin agents in this setting.
New research from a study of over 73,000 patients. People with high blood pressure, who don’t take their anti-hypertensive drug treatments when they should, have a greatly increased… read more.
Taken from JAMA – by Bruce Sylvester – After analyzing data on nearly 60,000 patients with acute ischemic stroke, researchers report that thrombolytic treatment initiated sooner correlates to… read more.
Taken from the NEJM – by Bruce Sylvester – Three biomarkers in the urine of kidney transplant recipients can be used to diagnose and predict transplant rejection, researchers… read more.
Taken from the BMJ – by Bruce Sylvester – The most common type of eating disorder diagnosed in the UK is not bulimia or anorexia, but, rather, “eating… read more.
Taken from the Lancet – by Bruce Sylvester – High doses of some non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of major vascular events (non-fatal heart attacks, strokes,… read more.
FDA Highlights by Bruce Sylvester – Lexapro (escitalopram), which is used to treat depression and anxiety, appears to improve a stress-related heart condition in persons with stable coronary… read more.
FDA Highlights by Bruce Sylvester – Researchers report that finasteride appears to reduce alcohol consumption in some men. The results were published online on June 13, 2013 by Alcoholism:… read more.
Four new biomarkers have been identified that can help in the early diagnosis of rheumatoid arthritis (RA), particularly among the one-third of patients who test negative for currently… read more.
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
